CHICAGO, Dec. 20, 2017 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at 5:00 pm PST in San Francisco.
A live audio webcast and replay of each presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay will be available for 90 days following the live webcast.
About R1 RCM
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, patient engagement strategies, or settings of care. The Company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more, visit r1rcm.com
Contact:
R1 RCM Inc.
Investor and Media Relations:
Atif Rahim
312.324.5476
[email protected]


SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Amazon Explores AI Content Marketplace With Media Publishers
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 



